Stonepine Capital Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Stonepine Capital Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$12,834,000
+56.5%
3,130,192
+36.3%
5.32%
+41.4%
Q4 2021$8,202,000
+753.5%
2,297,360
+769.9%
3.76%
+761.3%
Q3 2021$961,000
-70.5%
264,100
-78.1%
0.44%
-87.1%
Q3 2020$3,255,000
+811.8%
1,205,501
+697.3%
3.39%
+795.8%
Q1 2020$357,000151,1890.38%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders